Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Topics in Medicinal Chemistry
  4. Fast Track Articles
  5. Fast Track Article
image of WISP3/CCN6 Adipocytokine Marker in Patients with Non-alcoholic Fatty Liver Disease (NAFLD) and its Association with Some Risk Factors

Abstract

Introduction

CCN6/WISP3 is a member of the CCN adipokines family that can exert multiple effects on metabolic pathways. So far, the function of CCN6 in the pathogenesis of NAFLD has not been known well. Hence, we aimed to examine CCN6 serum levels in patients with NAFLD compared to healthy individuals and its association with some risk factors for the first time.

Method

This case-control study measured serum levels of CCN6, TNF-α, IL-6, adiponectin, and fasting insulin using ELISA kits in 88 NAFLD patients and 88 controls. In addition, other biochemical variables, including AST, ALT, lipid profiles, and FBG, were determined using an Auto analyzer instrument.

Results

A remarkable decrease in CCN6 levels was found in the NAFLD patients (1501.9543 ± 483.414 pg/ml) compared to the healthy group (1899.4856 ± 559.704 pg/ml, < 0.001). In NAFLD patients, a negatively notable correlation was observed between CCN6 and the levels of insulin ( = -0.278, = 0.011), HOMA-IR ( = -0.268, = 0.014), as well as TNF-α ( = -0.343, = 0.001). A remarkable association was found between CCN6 and the risk factor of NAFLD in the adjusted model for gender, age, and BMI with OR = 0.867 (95% CI, [0.806-0.931], < 0.001).

Conclusion

Our findings showed a significant reduction in CCN6 levels in the NAFLD patients compared to the healthy group, as well as the developing risk of NAFLD enhanced with the decrease of CCN6 levels.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ctmc/10.2174/0115680266334590241217065614
2025-02-11
2025-07-04

  • From This Site

    /content/journals/ctmc/10.2174/0115680266334590241217065614
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Luo Y. Lin H. Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease. Immun. Inflamm. Dis. 2021 9 1 59 73 10.1002/iid3.391 33332766
    [Google Scholar]
  2. Caturano A. Acierno C. Nevola R. Pafundi P.C. Galiero R. Rinaldi L. Salvatore T. Adinolfi L.E. Sasso F.C. Non-alcoholic fatty liver disease: From pathogenesis to clinical impact. Processes 2021 9 1 135 10.3390/pr9010135
    [Google Scholar]
  3. Vancells Lujan P. Viñas Esmel E. Sacanella Meseguer E. Overview of non-alcoholic fatty liver disease (NAFLD) and the role of sugary food consumption and other dietary components in its development. Nutrients 2021 13 5 1442 10.3390/nu13051442 33923255
    [Google Scholar]
  4. Divella R. Daniele A. De Luca R. Mazzocca A. Ruggieri E. Savino E. Casamassima P. Simone M. Sabba C. Paradiso A. Synergism of adipocytokine profile and ADIPOQ/TNF-α polymorphisms in NAFLD-associated MetS predict colorectal liver metastases outgrowth. Cancer Genomics Proteomics 2019 16 6 519 530 10.21873/cgp.20154 31659105
    [Google Scholar]
  5. Liu L. Shi Z. Ji X. Zhang W. Luan J. Zahr T. Qiang L. Adipokines, adiposity, and atherosclerosis. Cell. Mol. Life Sci. 2022 79 5 272 10.1007/s00018‑022‑04286‑2 35503385
    [Google Scholar]
  6. Escoté X. Gómez-Zorita S. López-Yoldi M. Milton-Laskibar I. Fernández-Quintela A. Martínez J. Moreno-Aliaga M. Portillo M. Role of omentin, vaspin, cardiotrophin-1, TWEAK and NOV/CCN3 in obesity and diabetes development. Int. J. Mol. Sci. 2017 18 8 1770 10.3390/ijms18081770 28809783
    [Google Scholar]
  7. Onyango A.N. Excessive gluconeogenesis causes the hepatic insulin resistance paradox and its sequelae. Heliyon 2022 8 12 e12294 10.1016/j.heliyon.2022.e12294 36582692
    [Google Scholar]
  8. Fernando D.H. Forbes J.M. Angus P.W. Herath C.B. Development and progression of non-alcoholic fatty liver disease: The role of advanced glycation end products. Int. J. Mol. Sci. 2019 20 20 5037 10.3390/ijms20205037 31614491
    [Google Scholar]
  9. Twigg S.M. Regulation and bioactivity of the CCN family of genes and proteins in obesity and diabetes. J. Cell Commun. Signal. 2018 12 1 359 368 10.1007/s12079‑018‑0458‑2 29411334
    [Google Scholar]
  10. Yeger H. CCN proteins: Opportunities for clinical studies—a personal perspective. J. Cell Commun. Signal. 2023 17 2 333 352 10.1007/s12079‑023‑00761‑y 37195381
    [Google Scholar]
  11. Song Y. Li C. Luo Y. Guo J. Kang Y. Yin F. Ye L. Sun D. Yu J. Zhang X. CCN6 improves hepatic steatosis, inflammation, and fibrosis in non‐alcoholic steatohepatitis. Liver Int. 2023 43 2 357 369 10.1111/liv.15430 36156376
    [Google Scholar]
  12. Ju L. Sun Y. Xue H. Chen L. Gu C. Shao J. Lu R. Luo X. Wei J. Ma X. Bian Z. CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis. Sci. Rep. 2020 10 1 3201 10.1038/s41598‑020‑60138‑8 32081971
    [Google Scholar]
  13. Pivovarova-Ramich O. Loske J. Hornemann S. Markova M. Seebeck N. Rosenthal A. Klauschen F. Castro J. Buschow R. Grune T. Lange V. Rudovich N. Ouwens D. Hepatic Wnt1 inducible signaling pathway protein 1 (WISP-1/CCN4) associates with markers of liver fibrosis in severe obesity. Cells 2021 10 5 1048 10.3390/cells10051048 33946738
    [Google Scholar]
  14. Wu W. Hu X. Zhou X. Klenotic P.A. Zhou Q. Lin Z. Myeloid deficiency of CCN3 exacerbates liver injury in a mouse model of nonalcoholic fatty liver disease. J. Cell Commun. Signal. 2018 12 1 389 399 10.1007/s12079‑017‑0432‑4 29214510
    [Google Scholar]
  15. Ni Y. Ni L. Zhuge F. Xu L. Fu Z. Ota T. Adipose tissue macrophage phenotypes and characteristics: The key to insulin resistance in obesity and metabolic disorders. Obesity 2020 28 2 225 234 10.1002/oby.22674 31903735
    [Google Scholar]
  16. Blüher M. Bashan N. Shai I. Harman-Boehm I. Tarnovscki T. Avinaoch E. Stumvoll M. Dietrich A. Klöting N. Rudich A. Activated Ask1-MKK4-p38MAPK/JNK stress signaling pathway in human omental fat tissue may link macrophage infiltration to whole-body insulin sensitivity. J. Clin. Endocrinol. Metab. 2009 94 7 2507 2515 10.1210/jc.2009‑0002 19351724
    [Google Scholar]
  17. Kefala G. Tziomalos K. Apoptosis signal-regulating kinase-1 as a therapeutic target in nonalcoholic fatty liver disease. Expert Rev. Gastroenterol. Hepatol. 2019 13 3 189 191 10.1080/17474124.2019.1570136 30791762
    [Google Scholar]
  18. Bian Z. Peng Y. You Z. Wang Q. Miao Q. Liu Y. Han X. Qiu D. Li Z. Ma X. CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice. J. Lipid Res. 2013 54 1 44 54 10.1194/jlr.M026013 23071295
    [Google Scholar]
  19. Lin Y. Wang Y. Li P. PPARα: An emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases. Front. Endocrinol. 2022 13 1074911 10.3389/fendo.2022.1074911 36589809
    [Google Scholar]
  20. Baker N. Sharpe P. Culley K. Otero M. Bevan D. Newham P. Barker W. Clements K.M. Langham C.J. Goldring M.B. Gavrilović J. Dual regulation of metalloproteinase expression in chondrocytes by Wnt‐1–inducible signaling pathway protein 3/CCN6. Arthritis Rheum. 2012 64 7 2289 2299 10.1002/art.34411 22294415
    [Google Scholar]
/content/journals/ctmc/10.2174/0115680266334590241217065614
Loading
WISP3/CCN6 Adipocytokine Marker in Patients with Non-alcoholic Fatty Liver Disease (NAFLD) and its Association with Some Risk Factors
Bentham Science Publishers ; https://doi.org/10.2174/0115680266334590241217065614
/content/journals/ctmc/10.2174/0115680266334590241217065614
/content/journals/ctmc/10.2174/0115680266334590241217065614
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: Insulin resistance ; Non-alcoholic Fatty Liver Disease ; Inflammation ; WISP3/CCN6 ; Adipocytokine

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test